Sign inJoin waitlistJoin the waitlist

Samuel Goldhaber

Associate Chief and Clinical Director, Division of Cardiovascular Medicine · Harvard School of Public Health

Credentials: · · · ·

History

division of cardiovascular medicine · Harvard School of Public Health
Present
Thrombosis Research Group · Boston University Medical Center
Present
Brigham and Women’s Hospital · Brigham and Women's Hospital
Present

Cardiovascular Disease
Brigham and Women's Hospital
1979–1982
Until 1979
Internal Medicine
Brigham and Women's Hospital
1976–1979
Harvard Medical School
1972–1976

Research

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice…
Chest · 2012 · 2,771 citations
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Review · Journal of the American College of Cardiology · 2020 · 2,153 citations
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
The Lancet · 1999 · First of 3 authors · 2,053 citations

Gregory Piazza
157 papers · 39 as a resident
Behnood Bikdeli
64 papers · 37 as a resident
HK
Harlan Krumholz
38 papers
CG
Charles Gibson
34 papers
Adrian Hernandez
30 papers
Charles Hennekens
28 papers
Robert Harrington
26 papers
Candrika Khairani
25 papers · 15 as a resident
Jean Connors
25 papers
UC
Umberto Campia
22 papers
Antoine Bejjani
19 papers · 19 as a resident
Suresh Vedantham
19 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $191.5K · Brigham and Women's Hospital
1997–1998
Biomedical Research Support Grant
National Center for Research Resources · S07
Project lead · Brigham and Women's Hospital

Clinical trials

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Principal investigator · Completed
Brigham and Women's Hospital
2016–2018
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Principal investigator · Completed · Phase 2
Daiichi Sankyo
2012–2014
Discharge ALERT: Quality Improvement Initiative
Principal investigator · Completed
Brigham and Women's Hospital
2009–2011
Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge
Principal investigator · Completed
Brigham and Women's Hospital
2008–2011